Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
A Phase IV Study in Subjects With Neurogenic Orthostatic Hypotension
This study has been terminated.
( Study was terminated due to poor enrollment )
Study NCT00046163 Information provided by Shire Pharmaceutical Development
First Received: September 20, 2002 Last Updated: November 2, 2007
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hypotension, Orthostatic
Additional conditions recognized in this trial
Hypotension
Shy-Drager Syndrome
More general conditions related to this trial
Autonomic Nervous System Diseases
Basal Ganglia Diseases
Brain Diseases
Cardiovascular Diseases
Central Nervous System Diseases
Movement Disorders
Multiple System Atrophy
Nervous System Diseases
Neurodegenerative Diseases
Vascular Diseases
Additional drug interventions recognized in this trial
Midodrine
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Agonists
Adrenergic alpha-Agonists
Autonomic Agents
Cardiovascular Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sympathomimetics
Therapeutic Uses
Vasoconstrictor Agents
Sponsors listed in this trial
Shire Pharmaceutical Development
Back to top of Main Content